2.0
14 June 2021
Current employee, more than 1 year
Cambridge, MA
Recommend
CEO approval
Business outlook
Pros
- Benefits(?) - Name Recognition on CV (???)
Cons
- Turnover within Immunology R&D is UNPARALLELED - Promotions are Political (Certain "Clusters" Reign Supreme) - ZERO Stratification of non-PhD vs PhD R&D Tracks (Poor Career Advancement) - Limited Pipeline (Feeds off Startup Buyouts) - Below Standard Industry Salaries for Cambridge MA... AND <2% Annual Raise